T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.57% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.16% |
| 4 | Industrials | 12.02% |
| 5 | Technology | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Darden Restaurants
DRI
$25.5B
| $15.4M | ﹤0.01% |
248,072
| – | – |
|
1202
Steel Dynamics
STLD
$37.5B
| $15.3M | ﹤0.01% |
762,628
-5,917,514
| -89% | -$110M |
|
|
BWLD
1203
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $15.3M | ﹤0.01% |
84,500
+7,254
| +9% | +$1.35M |
|
|
GLOG
1204
DELISTED
GASLOG LTD
GLOG
| $15.3M | ﹤0.01% |
788,210
-726,150
| -48% | -$13.6M |
|
1205
Fossil Group
FOSL
$324M
| $15.3M | ﹤0.01% |
185,076
-135,291
| -42% | -$12.4M |
|
|
NHC.PRA
1206
DELISTED
NATIONAL HEALTHCARE CORP PFD CONV SER A (DE)
NHC.PRA
| $15.2M | ﹤0.01% |
961,216
-19,423
| -2% | -$306K |
|
|
SHOR
1207
DELISTED
ShoreTel, Inc.
SHOR
| $15.1M | ﹤0.01% |
2,216,552
-452,810
| -17% | -$3.24M |
|
1208
Unum
UNM
$14.9B
| $15.1M | ﹤0.01% |
448,058
+10,500
| +2% | +$348K |
|
1209
Skywest
SKYW
$4.21B
| $15M | ﹤0.01% |
1,029,260
-7,860
| -0.8% | -$109K |
|
|
INFA
1210
DELISTED
INFORMATICA CORP
INFA
| $15M | ﹤0.01% |
342,798
-541,282
| -61% | -$22.5M |
|
|
YELL
1211
DELISTED
Yellow Corporation Common Stock
YELL
| $15M | ﹤0.01% |
835,970
+336,920
| +68% | +$6.24M |
|
|
TGNA
1212
DELISTED
TEGNA Inc
TGNA
| $14.9M | ﹤0.01% |
766,877
+75,315
| +11% | +$1.33M |
|
|
IMDZ
1213
DELISTED
Immune Design Corp.
IMDZ
| $14.8M | ﹤0.01% |
702,041
-47,100
| -6% | -$1.23M |
|
|
BID
1214
DELISTED
Sotheby's
BID
| $14.8M | ﹤0.01% |
350,136
-5,931
| -2% | -$253K |
|
1215
Atmos Energy
ATO
$28.7B
| $14.8M | ﹤0.01% |
267,490
+241,030
| +911% | +$13.3M |
|
|
HPY
1216
DELISTED
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
| $14.8M | ﹤0.01% |
315,735
-8,082
| -2% | -$410K |
|
1217
Donaldson
DCI
$11.1B
| $14.8M | ﹤0.01% |
391,742
+5,700
| +1% | +$213K |
|
1218
Huntington Bancshares
HBAN
$36.2B
| $14.8M | ﹤0.01% |
1,335,395
-20
| -0% | -$211 |
|
1219
Madison Square Garden
MSGS
$9.68B
| $14.7M | ﹤0.01% |
243,192
-1,216,593
| -83% | -$66.9M |
|
1220
Navient
NAVI
$852M
| $14.6M | ﹤0.01% |
718,243
-1,654,253
| -70% | -$34M |
|
1221
RenaissanceRe
RNR
$13.4B
| $14.6M | ﹤0.01% |
146,255
+134,283
| +1,122% | +$13.4M |
|
|
DST
1222
DELISTED
DST Systems Inc.
DST
| $14.6M | ﹤0.01% |
263,126
+21,000
| +9% | +$1.08M |
|
1223
Oceaneering
OII
$5.26B
| $14.5M | ﹤0.01% |
269,585
+826
| +0.3% | +$44.1K |
|
1224
H&R Block
HRB
$6.73B
| $14.5M | ﹤0.01% |
451,848
-2,910
| -0.6% | -$97.4K |
|
1225
Charter Communications
CHTR
$18.6B
| $14.5M | ﹤0.01% |
74,960
-799,080
| -91% | -$139M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.